These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 20062011)
1. Cyclin D1 immunoreactivity in normal endocervix and diagnostic value in reactive and neoplastic endocervical lesions. Little L; Stewart CJ Mod Pathol; 2010 Apr; 23(4):611-8. PubMed ID: 20062011 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic value and implications of vimentin expression in normal, reactive and neoplastic endocervical epithelium. Stewart CJ; Little L Pathology; 2010 Apr; 42(3):217-23. PubMed ID: 20350213 [TBL] [Abstract][Full Text] [Related]
3. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma. McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729 [TBL] [Abstract][Full Text] [Related]
4. Differential expression of cyclin-dependent kinase inhibitors and apoptosis-related proteins in endocervical lesions. El-Ghobashy AA; Shaaban AM; Innes J; Prime W; Herrington CS Eur J Cancer; 2007 Sep; 43(13):2011-8. PubMed ID: 17693084 [TBL] [Abstract][Full Text] [Related]
5. Keratin 17 Is a Prognostic Biomarker in Endocervical Glandular Neoplasia. Mockler D; Escobar-Hoyos LF; Akalin A; Romeiser J; Shroyer AL; Shroyer KR Am J Clin Pathol; 2017 Sep; 148(3):264-273. PubMed ID: 28821199 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of cdc6 in squamous and glandular neoplasia of the uterine cervix. Bonds L; Baker P; Gup C; Shroyer KR Arch Pathol Lab Med; 2002 Oct; 126(10):1164-8. PubMed ID: 12296751 [TBL] [Abstract][Full Text] [Related]
7. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma. Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933 [TBL] [Abstract][Full Text] [Related]
8. The expression of epithelial specific antigen in cervical intraepithelial neoplasia and adenocarcinoma. Markaki S; Lazaris D; Papaspirou I; Paulou V Eur J Gynaecol Oncol; 2004; 25(1):101-3. PubMed ID: 15053074 [TBL] [Abstract][Full Text] [Related]
9. Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis. Lee S; Rose MS; Sahasrabuddhe VV; Zhao R; Duggan MA Int J Gynecol Pathol; 2017 Jul; 36(4):310-322. PubMed ID: 27801764 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of p53 and bcl-2 proteins in neoplastic and non-neoplastic endocervical glandular lesions. McCluggage G; McBride H; Maxwell P; Bharucha H Int J Gynecol Pathol; 1997 Jan; 16(1):22-7. PubMed ID: 8986528 [TBL] [Abstract][Full Text] [Related]
11. Mucinous expression in benign and neoplastic glandular lesions of the uterine cervix. Baker AC; Eltoum I; Curry RO; Stockard CR; Manne U; Grizzle WE; Chhieng D Arch Pathol Lab Med; 2006 Oct; 130(10):1510-5. PubMed ID: 17090193 [TBL] [Abstract][Full Text] [Related]
12. Cyclin D1, E-cadherin and beta-catenin expression in FIGO Stage IA cervical squamous carcinoma: diagnostic value and evidence for epithelial-mesenchymal transition. Koay MH; Crook M; Stewart CJ Histopathology; 2012 Dec; 61(6):1125-33. PubMed ID: 23190089 [TBL] [Abstract][Full Text] [Related]
13. Apoptosis, proliferation, and expression of p53 and bcl-2 in endocervical glandular intraepithelial lesions and invasive endocervical adenocarcinoma. Ali-Fehmi R; Qureshi F; Lawrence WD; Jacques SM Int J Gynecol Pathol; 2004 Jan; 23(1):1-6. PubMed ID: 14668542 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of cyclins A and B as markers of neoplastic glandular lesions of the cervix. El-Ghobashy AA; Shaaban AM; Herod J; Innes J; Prime W; Herrington CS Gynecol Oncol; 2004 Feb; 92(2):628-34. PubMed ID: 14766257 [TBL] [Abstract][Full Text] [Related]
15. A pilot evaluation of a novel immunohistochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression (ProEx C) in cervical adenocarcinoma in situ, adenocarcinoma, and benign glandular mimics. Aximu D; Azad A; Ni R; Colgan T; Nanji S Int J Gynecol Pathol; 2009 Mar; 28(2):114-9. PubMed ID: 19188825 [TBL] [Abstract][Full Text] [Related]
16. p16 is superior to Stathmin-1 and HSP27 in identifying cervical dysplasia. Liou S; Nilforoushan N; Kang Y; Moatamed NA Diagn Pathol; 2021 Sep; 16(1):85. PubMed ID: 34544445 [TBL] [Abstract][Full Text] [Related]
17. Robust expression of EZH2 in endocervical neoplastic lesions. Makk E; Bálint L; Cifra J; Tornóczky T; Oszter A; Tóth A; Kálmán E; Kovács K Virchows Arch; 2019 Jul; 475(1):95-104. PubMed ID: 30903272 [TBL] [Abstract][Full Text] [Related]
18. Stathmin-1 expression as a complement to p16 helps identify high-grade cervical intraepithelial neoplasia with increased specificity. Howitt BE; Nucci MR; Drapkin R; Crum CP; Hirsch MS Am J Surg Pathol; 2013 Jan; 37(1):89-97. PubMed ID: 23211296 [TBL] [Abstract][Full Text] [Related]
19. New developments in endocervical glandular lesions. McCluggage WG Histopathology; 2013 Jan; 62(1):138-60. PubMed ID: 23134447 [TBL] [Abstract][Full Text] [Related]
20. Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1). Farley J; Gray K; Nycum L; Prentice M; Birrer MJ; Jakowlew SB Gynecol Oncol; 2000 Aug; 78(2):113-22. PubMed ID: 10926789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]